Shanghai Yaxin Biotechnology Co., Ltd. was
founded in 2008, which is a high-tech enterprise that focuses on
researching and producing the recombinant proteins.YaxinBio is the
first and only company on researching and producing the recombinant
carboxypeptidase B and recombinant trypsin. Animal-origin-free
enzymes are specially used in the human recombinant insulin
production, and exporting abroad.
Recombinant trypsin is used in the cell
culturing process,which conforms to the 2014 USP on the usage of
trypsin in the cell culture and the 2020 CP. Animal-origin-free is
very important for the production of antibody and vaccine.Usage of
recombinat trypsin fundamentally solves the problem of animal
original virus contamination in the human recombinant insulin
YaxinBio insists on “scientific and
technological innovation”, has developed with independent
intellectual property rights of the products.YaxinBio obtained the
support of Chinese ministry of science and technology and Shanghai
innovation fund project in 2010; The products recombinant trypsin,
recombinant carboxypeptidase B and recombinant protein A won the
Shanghai high-tech achievement transformation project in Sep.2013.
Biotechnology Co., Ltd. has the ability to produce and supply
high-purity and high-activity biological products, together with
complete supervision services, making the company the preferred
supplier of many leading international biopharmaceutical companies.